Cerrahpa\u015fa T\u0131p Fak\u00fcltesi N\u00fckleer T\u0131p Anabilim Dal\u0131nda T\u00fcrkiyede ilk kez n\u00f6roendokrin kanserli bir hastada Lu-177 DOTA TATE denilen radyon\u00fcklit bir ila\u00e7la tedavi uygulanm\u0131\u015ft\u0131r. Bu ila\u00e7 ticari olarak sat\u0131lan bir ila\u00e7 de\u011fildir. Hastanede \u00fcretilmesi gerekmektedir. Bu ilac\u0131 kendi ba\u015f\u0131na \u00fcretebilen d\u00fcnyada belli ba\u015fl\u0131 6-7 merkez vard\u0131r. Cerrahpa\u015fa T\u0131p Fak\u00fcltesi n\u00fckleer T\u0131p Anabilim Dal\u0131 Eczac\u0131l\u0131k Fak\u00fcltesi Farmas\u00f6tik Teknoloji Anabilim Dal\u0131 ile birlikte bu ilac\u0131 \u00fcretip hastalara uygulayabilen d\u00fcnyadaki say\u0131l\u0131 sa\u011fl\u0131k merkezlerinden biri haline gelmi\u015ftir. N\u00f6roendokrin kanserler ba\u015fl\u0131ca mide, barsak, pankreas ve akci\u011fer sisteminde g\u00f6r\u00fclen nadir kanserlerdir. Lutesyum 177 DOTA TATE radyoaktif bir ila\u00e7t\u0131r. Damar yolu ile hastaya serum i\u00e7erisinde verilir. Radyoaktif madde kanserli dokuyu \u00fczerindeki resept\u00f6rler yoluyla bularak yap\u0131\u015f\u0131r. B\u00f6ylece kanserli doku i\u00e7eriden \u0131\u015f\u0131nlan\u0131r. Radyoaktif madde yakla\u015f\u0131k 5 mm lik bir alan\u0131 \u0131\u015f\u0131nlar. Bu nedenle kanserli doku \u0131\u015f\u0131nlan\u0131rken normal dokular \u0131\u015f\u0131ndan zarar g\u00f6rmez. Tedavi s\u0131ras\u0131nda hasta herhangi bir yan etki hissetmez. Sa\u00e7 d\u00f6k\u00fclmesi, ishal, kusma, halsizlik olu\u015fmaz. Radyoaktif bir madde oldu\u011fu i\u00e7in hastalar 3 g\u00fcn boyunca \u00f6zel bir odada tutulurlar. Daha sonra da taburcu edilirler. Bu hastalar daha \u00f6nce bu tedaviyi alabilmek i\u00e7in yurt d\u0131\u015f\u0131na gitmek zorunda kal\u0131yorlard\u0131. Art\u0131k \u00fclkemizde de uygulanabildi\u011finden bu hastalar\u0131n yurt d\u0131\u015f\u0131na gitmelerine gerek kalmayacakt\u0131r. \u00dclkemiz sa\u011fl\u0131k sisteminin hem paras\u0131n\u0131 yurt d\u0131\u015f\u0131na aktarmas\u0131na gerek kalmayacak, ciddi parasal tasarruf sa\u011flanacak hem de bu tedaviye t\u00fcm yurtta\u015flar\u0131m\u0131z\u0131n ula\u015fabilmesi m\u00fcmk\u00fcn olacakt\u0131r.<\/p>\n
Ayr\u0131ca, Cerrahpa\u015fa T\u0131p Fak\u00fcltesi N\u00fckleer T\u0131p Anabilim dal\u0131nda Eczac\u0131l\u0131k fak\u00fcltesi Farmas\u00f6tik Teknolji Anabilim Dal\u0131 i\u015fbirli\u011fi ile g\u00f6r\u00fcnt\u00fclemede kullan\u0131lan ila\u00e7lar \u00fcretilmi\u015ftir. Bu ila\u00e7lar n\u00f6roendokrin kanserlerinin tan\u0131s\u0131nda kullan\u0131lan en ileri g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemlerinin kullan\u0131lmas\u0131na olanak sa\u011flam\u0131\u015ft\u0131r. \u00dcretilen bu malzeme ile son 3.5 ay i\u00e7erisinde \u00fclkemizin 150.000 Avro\u2019ya yak\u0131n para tasarrufu sa\u011flanm\u0131\u015ft\u0131r. \u00dcstelik \u00e7ok ileri g\u00f6r\u00fcnt\u00fcleme teknolojileri kullan\u0131larak hastal\u0131\u011f\u0131n tan\u0131s\u0131 daha kolay yap\u0131l\u0131r hale gelmi\u015ftir.<\/p>\n
Hem tedavi hem de t\u0131bbi g\u00f6r\u00fcnt\u00fclemede kullan\u0131lan bu ila\u00e7lar T\u00dcB\u0130TAK, \u00dcniversite Ara\u015ft\u0131rma Fonu ve Avrupa Birli\u011fi Ara\u015ft\u0131rma fonlar\u0131ndan sa\u011flanan kaynaklarla kurulan laboratuarda \u00fcretilerek sa\u011flanm\u0131\u015ft\u0131r. Bu amaca ula\u015fmak i\u00e7in verilen projeler \u00fczerinde 3 y\u0131ldan beri \u00e7al\u0131\u015f\u0131lmakta idi. Bug\u00fcn ama\u00e7lar\u0131m\u0131z\u0131n tamam\u0131na eri\u015filmi\u015ftir. Hedefimiz yeni ila\u00e7lar\u0131n geli\u015ftirilmesini sa\u011flamakt\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"
N\u00f6roendokrin kanserler nadiren g\u00f6r\u00fclen ancak son y\u0131llarda art\u0131\u015f e\u011filimi g\u00f6steren kan\u00adser t\u00fcrlerinden birisidir. \u00c7o\u011funlukla mide, ba\u011f\u0131rsak ve pankreasta, ikincil olarak da ak\u00adci\u011ferde ortaya \u00e7\u0131kar. Genellikle yava\u015f ilerler; hastalar, \u00e7ok uzun s\u00fcre belirti vermeksizin hastal\u0131kla ya\u015farlar. Tan\u0131s\u0131 genellikle tesad\u00fc\u00adfen konulur. Hastal\u0131\u011f\u0131n tan\u0131s\u0131 ve evrelemesi i\u00e7in \u015fimdilik \u00fclkemizde sadece bizim tara\u00adf\u0131m\u0131zdan \u00fcretilen g\u00f6r\u00fcnt\u00fcleme y\u00f6nteminin kullan\u0131lmas\u0131 gerekir.<\/p>\n","protected":false},"author":1,"featured_media":380,"parent":16,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"page-parent.php","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"class_list":["post-22","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/pages\/22","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/comments?post=22"}],"version-history":[{"count":2,"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/pages\/22\/revisions"}],"predecessor-version":[{"id":600,"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/pages\/22\/revisions\/600"}],"up":[{"embeddable":true,"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/pages\/16"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/media\/380"}],"wp:attachment":[{"href":"https:\/\/www.leventkabasakal.com\/en\/wp-json\/wp\/v2\/media?parent=22"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}